09.01.2019 - In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)